Get started
Author

Juan Carlos Percovich

Observed names: J C Percovich, J. C. Percovich, J.C. Percovich, Juan C. Percovich, Percovich, Juan Carlos
Observed institutions: Cliniques Universitaires Saint-Luc, Amsterdam UMC Location University of Amsterdam, Hospital General Universitario Gregorio Marañón, Hospital Universitario Príncipe de Asturias, Amsterdam University Medical Centers, University of Amsterdam
ORCID: 0000-0002-9244-6872
Observed ORCID: 0000-0002-9244-6872
OpenAlex ID: A5012911739
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study
2019 · Alberto Carmona-Bayonas, Paula Jiménez-Fonseca, et al. · Journal of Clinical Oncology · 84
Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study
2023 · Mercedes Mitjavila, Paula Jimenez-Fonseca, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 67
PDF
Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome
2023 · Vincent Amodru, Amandine Ferriere, et al. · European Journal of Endocrinology · 49
PDF
Adrenal venous sampling in primary aldosteronism: Experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register)
2022 · Marta Araujo-Castro, Miguel Paja Fano, et al. · Endocrine · 37
High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery
2023 · Kristina Isand, Richard Feelders, et al. · European Journal of Endocrinology · 34
PDF
Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes
2023 · Marta Araujo-Castro, Miguel Paja Fano, et al. · Endocrine Connections · 32
PDF
Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study
2022 · Dominique Clement, Shaunak Navalkissoor, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 32
PDF
Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases
2024 · Marta Araujo-Castro, Betina Biagetti, et al. · The Journal of Clinical Endocrinology & Metabolism · 31
PDF
Predictive model of hypertension resolution after adrenalectomy in primary aldosteronism: the SPAIN-ALDO score
2022 · Marta Araujo-Castro, Miguel Paja Fano, et al. · Journal of Hypertension · 23
Control glucémico en pacientes hospitalizados no críticos
2011 · Marta Botella, José Antonio Rubio, et al. · Endocrinología y Nutrición · 20
Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response
2023 · Jorge Gabriel Ruiz-Sánchez, Miguel Paja-Fano, et al. · The Journal of Clinical Endocrinology & Metabolism · 18
PDF
Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion
2024 · Betina Biagetti, Marta Araujo-Castro, et al. · European Journal of Endocrinology · 17
PDF
Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
2024 · Eider Pascual-Corrales, Betina Biagetti, et al. · Pituitary · 13
Glycemic control in non-critical hospitalized patients
2011 · Marta Botella, José Antonio Rubio, et al. · Endocrinología y Nutrición (English Edition) · 13
External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study
2021 · Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, et al. · Neuroendocrinology · 12
PDF
Differences in the presentation and evolution of primary aldosteronism in elderly (≥65 years) and young patients (<65 years)
2022 · Paola Parra Ramírez, Patricia Martín Rojas-Marcos, et al. · Endocrine Connections · 9
PDF
Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register
2023 · Paola Parra Ramírez, Patricia Martín Rojas-Marcos, et al. · Endocrine · 7
PDF
Prevalence, risk factors and evolution of diabetes mellitus after treatment in primary aldosteronism. Results from the SPAIN-ALDO registry
2023 · M. Araujo-Castro, M. Paja Fano, et al. · Journal of Endocrinological Investigation · 7
Efficacy and safety of 177Lu-DOTATATE in patients (pts) with advanced pancreatic neuroendocrine tumors (pNETs): Data from the NETTER-R international, retrospective registry.
2021 · Dominique Clement, Shaunak Navalkissoor, et al. · Journal of Clinical Oncology · 5
Conservative Management of Sclerosing Mucoepidermoid Carcinoma with Eosinophilia of the Thyroid Gland: 12 Years Follow-Up after an Atypical Initial Therapy
2017 · Maria Requena, Juan C. Percovich, et al. · Advances in Diabetes & Endocrinology · 4
PDF
Tumor mesenquimal variante no fosfatúrica: a propósito de un caso
2021 · Montenegro, Alejandra Maricel Rivas, Ramos, Roberto José Añez, et al. · Redalyc (Universidad Autónoma del Estado de México)
Development and internal validation of a predictive nomogram of progression-free survival in well-differentiated stage IV gastroenteropancreatic neuroendocrine tumours treated with somatostatin analogues: GETNE-TRASGU study
2018 · R. Garcia-Carbonero, V. Alonso, et al. · Annals of Oncology
Evaluation of neurofibromatosis type 1 and gastroenteropancreatic neuroendocrine tumors.
2018 · Juan Carlos Percovich, Jose Atencia, et al. · Endocrine Abstracts
Works count: 23
Citation count: 514
H-index: 13
I10-index: 15
Year
Topic
Type